Huma is an England-based digital health technology company that provides solutions such as remote patient monitoring and clinical trials for physicians.
$80M
Jul 15, 2024
-
SmartCella is a Sweden-based holding company that owns and operates companies in biotech and medtech.
$54M
Jul 07, 2024
-
Nucleus RadioPharma is a North Carolina-based CDMO that provides services such as clinical trial manufacturing and quality assurance for biotechnology and pharma companies.
-
Jun 03, 2024
-
Cellectis is a France-based biopharmaceutical company that researches and develops T-cell immunotherapies for the treatment of cancer.
$140M
May 05, 2024
-
Asher Bio is a California-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and infectious diseases.
$55M
Apr 15, 2024
-
Frequently Asked Questions about AstraZeneca
What is AstraZeneca investing in?
AstraZeneca has invested in 21 companies including Huma, SmartCella and Nucleus RadioPharma
What company did AstraZeneca invest in?
AstraZeneca invested in a total 21 companies including Huma, SmartCella and Nucleus RadioPharma
What are the top 5 investments by AstraZeneca?
The top companies in which AstraZeneca invested are Huma, SmartCella, Nucleus RadioPharma, Cellectis and Asher Bio
